Coexpression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor cMET predict recurrence of meningiomas

Cancer Letters

Volumn 213, Issue 1, 2004, Pages 117-124

  Martínez Rumayor, Abelardo ^a   Arrieta, Oscar ^a,b,c   Guevara, Patricia ^a   Escobar, Elizabeth ^a   Rembao, Daniel ^b   Salina, Citlaltepetl ^b   Sotelo, Julio ^a,c  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b Insurgentes Sur 3877 14269 Mex C   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

cMET receptor; Hepatocyte growth factor; Predictive factor; Recurrence of meningiomas; Scatter factor

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT MENINGIOMA; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 4344594389     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.04.026     Document Type: Article

References (28)

1. Y. Miwa, P.M. Harrison, F. Farzaneh, P.G. Langley, R. Williams, and R.D. Hudges Plasma levels and hepatic mRNA expression of transforming factor-beta 1 in patients with hepatic fulminant failure J. Hepatol. 27 1997 780 788
2. M.M. Bhargava, A. Joseph, J. Knesel, R. Halaban, Y. Li, and S. Pang Scatter Factor and hepatocyte growth factor: activities, properties and mechanism Cell Growth. Differ. 3 1992 11 20
3. P. Boros, and C.M. Miller Hepatocyte growth factor: a multifunctional cytokine Lancet 345 1995 293 295
4. M.C. Stella, and P.M. Comoglio HGF: a multifunctional growth factor controlling cell scattering Int. J. Biochem. Cell. Biol. 31 1999 1357 1362
5. V. Neaud, S. Faouzi, J. Guirouilh, B. Le Bail, C. Balabaud, P. Bioulac-Sage, and J. Rosenbaum Human hepatic myofibroblast increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor Hepatology 26 1997 1458 1466
6. F. Bussolino, M.F. Di Renzo, M. Ziche, E. Bocchietto, M. Olivero, and L. Naldini Hepatocyte growth factor is a potent angiogenic factor which stimulates cell motility and growth J. Cell. Biol. 119 1992 629 641
7. R. Ramirez, D. Hsu, A. Patel, C. Fenton, C. Dinauer, R.M. Tuttle, and G.L. Francis Over-expression of Hepatocyte Growth Factor/Scatter Factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adult with papillary thyroid carcinoma Clin. Endocrinol. 53 2000 635 644
8. S. Mine, T. Fujisaki, C. Kawahara, T. Tabata, T. Iida, M. Yasuda, T. Yoneda, and Y. Tanaka Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44 Exp. Cell Res. 288 2003 189 197
9. G. Davies, M.D. Mason, T.A. Martin, C. Parr, G. Watkins, and J. Lane The HGF/SF antagonist NK4 reverses fibroblast and HGF-induced prostate tumour growth and angiogenesis in vivo Int. J. Cancer 106 2003 348 354
10. K. Matsumoto, and T. Nakamura NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics Cancer. Sci. 94 2003 321 327
11. K. Lamszus, L. Ulrike, N.O. Schmidt, D. Stavrou, S. Ergun, and M. Westphal Vascular VEGF, HGF/SF, FGF and PGF in human meningiomas and their relation to angiogenesis and malignancy Neurosurgery 46 2000 938
12. T. Moriyama, H. Kataoka, H. Kawano, k. Yokogami, S. Nakano, and T. Goya Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans Cancer Lett. 124 1998 149 155
13. L. DeAngelis Brain tumors New Eng J Med 344 2001 114 123
14. D. Simpson The recurrence of intracranial meningiomas after surgical treatment J. Neurol. Neurosurg. Ps. 20 1957 22 39
15. O. Arrieta, E. García, P. Guevara, R. García-Navarrete, and J. Sotelo Hepatocyte Growth Factor is associated with poor prognosis of malignant gliomas and it is a predictor for recurrence of meningioma Cancer 3210 2002 3218
16. F. DeMonte A.H. Kaye E.R. Laws Jr. Meningiomas Brain Tumors 2001 Churchil Livingstone New York 721
17. P. Kleihues, D.N. Louis, B.W. Scheithauer, L.B. Rorke, G. Reifenberger, P.V. Burger, and W.K. Cavenee The WHO Classification of tumors of the Nervous System J. Neuropath. Exp. Neurol. 61 2002 215 225
18. M. Salcman O. Al-Mefty Malignant meningiomas Meningiomas 1991 1991 Raven Press New York 75 85
19. M. Baird, and P.J. Gallagher Recurrent intracranial and spinal meningiomas: clinical and histological features Clin. Neuropathol. 8 1989 41 44
20. H. Zankl, and K.D. Zang Correlations between clinical and and cytogenetical data in 180 human meningiomas Cancer Genet. Cytogen. 1 1980 351 356
21. P.L. May, J.C. Broome, J. Lawry, R.A. Buxton, and R.D. Battersby The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material J. Neurosurg. 71 1989 347 351
22. T. Hoshino, T. Nagashima, J.A. Murovic, C.B. Wilson, and R.L. Davis Proliferative potential of human meningiomas of the brain: a cell kinetic study with bromodeoxyuridine Cancer 58 1986 1466 1472
23. L.S. Chin, and D.R. Hinton The standardized assessment of argyrophilic nucleolar organizer regions in meningeal tumors J. Neurosurg. 74 1991 590 596
24. L.A. Langford, and C.S. Cooksley Comparison of MIB-1 (Ki-67 antigen) and bromodeoxyuridine proliferation indexes in meningiomas Hum. Pathol. 27 1996 350 354
25. L.A. Langford, M.A. Piatyszek, R. Xu, S.C. Schold Jr., W.E. Wright, and J.W. Shay Telomerase activity in ordinary meningiomas predicts poor outcome Hum. Pathol. 28 1997 416 420
26. G. Di Chiro, J. Hatazawa, D.A. Katz, H.V. Rizzoli, and D.J. De Michele Glucose utilization by intracranial meningiomas as an index of tumor aggressiveness and probability of recurrence: A PET study Radiology 164 1987 521 526
27. P.E. Fewings, R.D. Battersby, and W.R. Timperley Long term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence? J. Neurosurg. 92 2000 401 405
28. K.E. Friend, R. Radinsky, and I.E. McCutcheon Growth hormone expression and function in meningiomas: effect of a specific receptor antagonist J. Neurosurg. 91 1999 93 99